Recent Articles from Investor Brand Network

A bill in the Nebraska Legislature aimed at helping put voter-approved medical marijuana laws into action did not pass on Tuesday. Despite strong support from voters last November, lawmakers couldn’t overcome a filibuster in the chamber. Legislative Bill 677 fell short of the 33 votes needed to end debate, with a narrow 23-22 vote failing to move it forward.

ESGold (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D), a fully permitted, pre-production resource company on a clear path to near-term gold and silver production, recently reported the identification of a significant geophysical anomaly in the southwest portion of its Montauban Project in Quebec. “According to a company press release, internal analysis of historical VTEM (Versatile Time Domain Electromagnetic) survey data and drill records has highlighted this area as a high-priority exploration target,” reads a recent article. “The zone, which has not yet been tested by drilling, displays a strong combination of electromagnetic conductivity and magnetic response, a dual signal often associated with buried, sulfide-rich VMS (volcanogenic massive sulfide) deposits. These types of systems are typically high in base and precious metals, including copper, zinc, and gold.”

ONAR (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. “Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide,” reads a recent article discussing the company. “Built on a foundation of innovation and operational excellence, ONAR’s vision is to redefine marketing services by leading with technological advancement. ONAR’s strategic growth model focuses on growing and acquiring proven agencies under one umbrella to deliver superior service offerings across industries.”

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior mining company based in British Columbia, has recently been the focus of a comprehensive analysis by Noble Capital Markets Research ( https://ibn.fm/3CDHY ). The report gave the company an “Outperform” rating and a 12-month price target of C$0.70 and US$0.50 per share while highlighting Nicola Mining’s diversified asset base and cash-generating operations as key factors supporting this valuation.

Gold ticked upwards on Monday following the weakening of the U.S. dollar after Moody’s downgraded the government of America’s credit rating . This boosted the safe haven appeal of gold and helped the precious metal to register some gains on the day .

Beam Therapeutics (NASDAQ: BEAM), a biotechnology firm pioneering precision genetic medicines via base editing, announced it will present updated data from its BEACON Phase 1/2 trial of BEAM-101 at the European Hematology Association 2025 Congress, June 12-15 in Milan. BEAM-101 is an investigational, one-time ex vivo cell therapy targeting severe vaso-occlusive crises in sickle cell disease (SCD). The new data, covering safety and efficacy outcomes in 17 patients, will be highlighted during multiple poster sessions on June 13, underscoring BEAM-101’s potential to provide a durable treatment by addressing the root cause of SCD. Additional presentations will explore biomarkers, manufacturing advances, and red blood cell health post-treatment. Beam will also host a webcast on June 13 at 4:00 p.m. ET to review EHA highlights.

In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is at the forefront of this effort with its development of SGX943 (dusquetide), a novel broad-spectrum therapy designed to combat bacterial infections without relying on traditional antibiotics.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics, Inc., a medical and technology-driven company, are expanding their footprint in the mental health care sector with the acquisition of Kadima Neuropsychiatry Institute in La Jolla, California. The companies announced the signing of a definitive agreement to purchase the institute earlier in May 2025. Kadima is expected to serve as the clinical template for HOPE’s planned network of interventional psychiatry clinics across the U.S. ( https://ibn.fm/uwHMj ).

Nearly 50% of all small- and mid-cap stocks in the oil and gas industry in America are being sold and bought at less than the firms’ book values, the worst level from the pandemic era. This trend has piqued the interest of value investors, particularly those who follow the Ben Graham and Warren Buffett school of thought. Stocks that are priced lower than the assets on their books present classic value investing opportunities dubbed “cigar butts”, and energy companies are currently full of them.

A big decision was made in the United States that could change how solar panels are bought and sold in the country. The U.S. International Trade Commission (ITC) voted that American solar panel makers are being harmed by cheap imports coming from Southeast Asia. This vote is an important step that allows the U.S. government to put high taxes, known as tariffs, on solar panels from four countries: Malaysia, Thailand, Cambodia, and Vietnam.

As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market in the process. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower access, private credit firms like FAVO Capital (OTC: FAVO) are emerging as essential players in the financial ecosystem. Backed by scalable technology, a seasoned leadership team, and a growing syndication network, FAVO is positioning itself for outsized growth at the intersection of policy tailwinds, market demand, and digital transformation.

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) reported $58.2 million in net income for the fiscal year ended March 31, 2025, up 60% from the prior year, on revenue of $298.9 million, a 39% increase. Fiscal 2025 production included 7.5K oz of gold, 6.9M oz of silver, 62.2M lb of lead and 23.3M lb of zinc. The company also posted adjusted earnings of $75.1 million or $0.37 per share, with cash flow from operations reaching $138.6 million. In Q4, Silvercorp reported a net loss of $7.6 million due to a $20.6 million non-cash derivative charge, but adjusted quarterly net income came in at $14.7 million. The company ended the quarter with $369.1 million in cash and short-term investments, supported by strong output at its Ying and GC mines and continued development of the El Domo project.

A recent report from the Energy Industries Council (EIC) has revealed that Europe’s transition to renewable energy could be hindered by industrial bottlenecks, permitting delays, and grid issues. The continent has made significant strides in adopting clean energy, especially in countries like Sweden, Finland, and Portugal, but grid and supply chain issues threaten to handicap the continent’s progress.

The U.S. Senate recently voted 66-22 to move forward with the GENIUS Act, a new proposal focused on regulating parts of the crypto world. While the bill stirred debate in recent weeks, especially among Democrats skeptical of President Donald Trump’s involvement in crypto ventures, it still earned the backing of 16 Democrats, including Senators Cory Booker and Adam Schiff.

For years, crypto promised to change the world. It was supposed to make money systems fair, remove middlemen, and give power back to the people. But instead of keeping these promises, much of the crypto world got caught up in quick profits, hype, and meme coins. The dream of decentralization got lost. Now, there’s a new hope, artificial intelligence (AI). And this time, it might just be the second chance crypto needs .

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S. launch in 2025, as it is progressing through the FDA clearance process for its Intelligent Fingerprinting Drug Screening System. The non-invasive device, which detects recent drug use via fingerprint sweat, is gaining international traction for its speed, portability, and ability to integrate into a range of safety-critical environments.

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) has published its 2024 Sustainability and Climate Change Reports, detailing advances in ESG integration, climate risk management, and stakeholder impact. The company received top-tier ESG ratings from Sustainalytics, MSCI, and ISS, and was named to Corporate Knights’ 2025 Global 100 and Canada’s Best 50 list. In 2024, 100% of new streaming deals were ESG-screened, and 99% of production came from mines aligned with the Global Industry Standard on Tailings Management. Wheaton contributed over $8.5 million to global causes, with $6 million directed to partner site communities. The Climate Change Report notes 86% of financed emissions have science-aligned targets and includes updates aligned with ISSB’s new S2 standard.

SOBRsafe (NASDAQ: SOBR), a leader in next-generation alcohol detection technology, reported strong results for the first quarter ended March 31, 2025, with revenue increasing 80.5% year-over-year to $86.6K and gross margin improving to 58.8%. Net loss narrowed to $1.9 million from $2.5 million a year ago, driven by increased software subscriptions and SOBRsure(TM) device sales. Software subscription revenue, now 53.8% of total revenue, more than doubled. The company deployed 148 SOBRsure(TM) devices, a 41% increase from year-end, and strengthened its leadership with key board and advisory additions. SOBRsafe ended the quarter with $10.1 million in cash following $3.3 million in warrant exercises tied to its October 2024 PIPE financing.

A new measure making its way through Delaware’s state legislature could change how and where THC-infused beverages are sold. House Bill 98, introduced by Representative Debra Heffernan, proposes moving these drinks out of bars and restaurants and limiting their sale to licensed package stores. The bill has already passed the committee stage, and Heffernan expects it to become law before the legislative session ends.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell lymphoma (“CTCL”), a rare form of cancer that affects the skin. “Soligenix’s proprietary treatment, HyBryte(TM), is currently in clinical trials, and the latest results have shown promising efficacy in treating CTCL,” reads a recent article. “‘Following 18 weeks of treatment, 75% of patients achieved ‘Treatment Success,’ reinforcing HyBryte(TM) as a potentially safe and fast-acting therapy for this chronic and underserved cancer,’ the company reported. The study results suggest that the treatment may be highly effective in reducing the symptoms of CTCL, providing much-needed hope for patients with this challenging condition.”

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The innovative platform not only targets cancer cells effectively but also minimizes harm to surrounding healthy tissues, potentially improving treatment outcomes and reducing side effects. As global cancer rates continue to rise, Calidi’s RTNova platform and tumor-specific virotherapy hold the promise of offering new hope to cancer patients, addressing the limitations of existing treatments, and potentially improving survival rates across multiple cancer types. The company’s ongoing research and deep commitment to scientific excellence position it at the forefront of next-generation cancer care.

Newton Golf Company (NASDAQ: NWTG) is revolutionizing golf performance through its high-quality, custom-fitted shafts engineered to match individual swing dynamics. Recognizing the shaft as the “engine” of the club, Newton leverages advanced technology to optimize swing speed, ball trajectory and overall control. Crafted in the U.S. and engineered to meet the demands of players on professional tours, 30 PGA TOUR Champions players trust the shaft—including major winner Doug Barron. From seasoned pros to players across all skill levels, the company delivers precision equipment that minimizes inconsistencies and enhances shot accuracy for all golf enthusiasts. As personalized equipment gains traction in the golf industry, Newton Golf is emerging as a leader, helping players unlock their true potential on the course.

Pre-production gold and silver resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF) has a positive outlook for the precious metals as company officers promote insights to its unique clean extraction model and revenue strategy, which is focused on its permitted asset in a Quebec historic resource.

In a recent report to shareholders, Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan shared significant company achievements and milestones as well as his expectations for 2025 ( https://ibn.fm/9K5zT ). At the center of the company’s positive outlook for future is noteworthy progress made toward the commercialization of its proprietary Aversa technology, including a strong partnership with Kindeva Drug Delivery.

Fusion Fuel Green (Nasdaq: HTOO) announced its majority-owned subsidiary, Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), secured approximately $2.7 million in new engineering contracts since March 2025. Additionally, the subsidiary added more than 1,800 residential service contracts and two commercial contracts since January, boosting expected recurring revenue by over $900,000. Al Shola Gas now serves over 12,000 customers and supplies more than 600 MT of LPG monthly, with plans to reach 800 MT by year-end.

Structural batteries that merge structural strength with battery power could open the door to a new age of electric mobility. Lithium-ion batteries are used to power most electric cars due to their high energy density, longevity, and long life cycles. However, current EV battery technology still has plenty of room for improvement. Modern EV battery packs are heavy, costly, have a moderate risk of catching fire , and often come with repair and maintenance challenges.

The United Arab Emirates (UAE) and the United States are deepening their energy ties, with the landmark agreements set to channel billions of dollars into joint oil and gas ventures. These deals mark a new phase in the United States-United Arab Emirates cooperation, reinforcing a shared vision of long-term energy security and economic growth.

Researchers have developed a novel brain tumor test that surgical experts have dubbed a game changer. This is because the test collapses the needed time to obtain an accurate diagnosis to just hours rather than multiple weeks as has been the case.

A recent study has revealed that AI is having a dramatic and sometimes overwhelming effect on the working lives of people across the UK. The research, carried out for Henley Business School and involving over 4,500 participants from nearly 30 industries, paints a complex picture of both excitement and concern.

With over 5.5 million new business applications filed in the U.S. last year alone, small- to medium-sized businesses (“SMBs”) are thriving, but many are finding themselves underserved by traditional financial institutions. According to recent industry insights, 6 in 10 SMBs are denied access to essential funding due to outdated underwriting processes that fail to reflect their real financial health.

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) announced it will present a live virtual corporate update hosted by Red Cloud Financial Services on June 5, 2025, at 2:00 p.m. ET. The company plans to share insights into its 10 optioned properties from Denison Mines Corp. in the Athabasca Basin and discuss its strategy for advancing one of North America’s key uranium portfolios. A live Q&A will follow the presentation, and a replay will be made available to all registrants.

Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel Bradley will speak May 24 at Beyond Expo 2025 in Macau, China—Asia’s leading consumer tech conference. Bradley will join the Sports Technology panel to highlight how Datavault AI’s patented tools like ADIO(R), DVHOLO(TM) and VerifyU(TM) enable athletes to convert name, image and likeness (NIL) data into secure, revenue-generating tokens. The company’s system supports real-time NIL minting and monetization through its Information Data Exchange(R), helping institutions and athletes tap into the projected $2.55 billion NIL market.

GivBux (OTC: GBUX) announced that June 5, 2025, is the ex-dividend date for its previously declared special warrant dividend. Under the terms, shareholders will receive one warrant for every 10 shares held, allowing the purchase of GBUX stock at $4.00 per share. To qualify, investors must own GBUX shares by June 4, 2025. The warrants will be distributed electronically on June 5, and the company will serve as its own warrant agent.

NanoViricides, Inc. (NYSE American: NNVC) President Dr. Anil Diwan applauded the FDA’s updated COVID-19 booster shot policy, which now limits widespread recommendations and focuses on high-risk groups such as seniors and those with co-morbidities. Diwan praised the shift to evidence-based guidance and emphasized how the new policy aligns with global standards. He added that broad public immunity and limited booster uptake highlight the need for alternatives. Diwan pointed to the company’s NV-387 antiviral as a potential future solution to reduce reliance on vaccines.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced that CEO Seth Lederman, M.D., participated in a fireside chat at A.G.P.’s Annual Healthcare Company Showcase. The event provided a platform for biotech leaders to share strategic updates, with Lederman highlighting Tonix’s integrated business model, marketed products, and advancing clinical pipeline.

Lahontan (TSX.V: LG) (OTCQB: LGCXF) is a Canadian mine development and exploration company advancing a portfolio of gold and silver assets in Nevada’s Walker Lane, one of the world’s most productive and mining-friendly regions. Through its U.S. subsidiaries, the company controls four gold and silver properties in Nevada, three of which are 100%-owned and one under a low-cost option to acquire full ownership. With a clear near-term path to production, Lahontan is focused on unlocking oxide gold and silver value from past-producing, infrastructure-ready projects.

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will join a Water Tower Research Fireside Chat on May 29, 2025, at 11 a.m. ET. The discussion will cover Cybin’s CYB003 Phase 3 program, recent clinical partnerships, its collaboration with Thermo Fisher, and insights on the evolving regulatory landscape for psychedelics. The event will also explore Cybin’s strategy in interventional psychiatry and its alliance with Osmind.

Coinbase, the largest crypto exchange in the United States, has revealed that a recent cybersecurity breach affecting some of its users may cost the company between $180 million and $400 million. The estimated loss doesn’t include the $20 million ransom demand made by the attackers, which Coinbase firmly declined to pay.

Freight trains could be used to circumvent grid connection bottlenecks by hauling batteries filled with renewable energy across the country. Despite a massive increase in America’s green energy capacity, a significant portion of the country’s renewable energy still isn’t connected to the grid due to transmission and interconnection bottlenecks. Instead of waiting several years to connect to the grid, green energy projects could deliver their energy to end users via freight train.

Nebraska lawmakers have taken a firm stance on cryptocurrency mining by passing a new bill aimed at controlling the energy consumption of large-scale operations. The bill, LB 526, received unanimous support in the state legislature and now awaits action from Governor Jim Pillen. If he signs it, or takes no action within five legislative days (excluding Sundays), it will automatically become law, going into effect on October 1, 2025.

Intelligent Bio Solutions (Nasdaq: INBS) announced its participation at the RISE25 conference in Kissimmee, Florida, from May 28 to 31, 2025, where it will support U.S. distribution partner SMARTOX. INBS will demonstrate its Intelligent Fingerprinting Drug Screening System—a non-invasive, rapid test using fingerprint sweat to detect substances like THC, cocaine, methamphetamine, and opiates. With results delivered in under ten minutes, the technology is well-suited for treatment courts and justice applications. INBS views the event as a key platform to engage stakeholders as it advances toward U.S. market entry.

Albuquerque, New Mexico, has launched a new basic income initiative aimed at helping families in areas with high needs. Starting this month, selected households will receive monthly payments with no strings attached. This effort is being partially funded by tax revenue generated from recreational marijuana sales.

Tesla (NASDAQ: TSLA) is set to launch its robotaxi service in Austin, Texas, in June 2025, starting with a limited fleet of approximately 10 vehicles and aiming to scale up to 1,000 within a few months. The rollout will be invite-only and will utilize teleoperators to assist when the autonomous system encounters difficulties. CEO Elon Musk emphasized that the robotaxis will be geofenced to operate only in selected safe areas and will avoid complex intersections unless the system is highly confident in their safety. This cautious approach follows a Business Insider report detailing a test where Tesla’s Full Self-Driving (FSD) Supervised software ran a red light in San Francisco. Musk criticized the comparison, arguing that the test did not accurately reflect the performance of the autonomous software intended for robotaxis, which will be FSD Unsupervised.

Traders Fair Philippines, the region’s premier financial event, returns to Manila on May 24, 2025, at Edsa Shangri-La for a full-day of education, networking, and market insights. Organized by iEvents, the fair will bring together traders, investors, brokers, and financial service providers for a dynamic showcase of industry trends across forex, cryptocurrency, stocks, futures, and options. The event will feature more than 20 esteemed speakers, including leaders from Forex Trading Philippines, PAFTI, and Wise Investors Ph, and offer engaging presentations and workshops. Traders Fair Philippines is part of a global series renowned for fostering professional development and market connectivity across Asia, Africa, LATAM, and other key regions.

Trump Media & Technology Group (NASDAQ: DJT) is under scrutiny following revelations that U.S. Attorney General Pam Bondi sold between $1 million and $5 million worth of the company’s shares on April 2, 2025—the same day President Donald Trump announced significant new tariffs that led to a market downturn. Bondi’s financial disclosure forms indicate the transactions occurred on that date, though it’s unclear whether they were made before or after the market closed. The timing has raised questions about potential conflicts of interest, especially given Bondi’s prior consultancy role with Digital World Acquisition Corp., the special purpose acquisition company that merged with Trump Media to take it public. While Bondi was obligated to divest her holdings within 90 days of her confirmation as attorney general, the specific timing of the sale has prompted calls for further investigation.

Marketing is undergoing a once-in-a-generation transformation, powered by artificial intelligence, real-time data, and next-generation automation. Today’s marketing systems aren’t static; they’re dynamic, adaptive, and personalized in real time. For growth-stage and middle-market businesses, this shift presents both a challenge and an opportunity. Navigating this landscape requires tools that are flexible, insights that are deep, and strategies grounded in data. That’s precisely where ONAR Holding Corp. (OTCQB: ONAR) is establishing itself as a market leader.

SKYX Platforms (NASDAQ: SKYX) announced a major collaboration with SG Holdings for a $3 billion smart city development in Miami’s Little River District. The company will deploy over 500,000 units of its patented plug-and-play smart home technologies across 5,700 planned residences, including affordable housing. SKYX’s platform will power safety and smart features such as voice and app controls, 911 emergency calling, smoke and CO detectors, and more. The project, backed by U.S. and global manufacturers, marks the first development of its kind in Florida and establishes recurring revenue opportunities through subscriptions, monitoring services, and future integrations.

Lelantos Holdings (OTC PINK: LNTO) announced a comprehensive 2025 strategy through its subsidiary, Lelantos Energy, aimed at expanding renewable energy access, advancing credit monetization, and serving underserved communities. Key initiatives include a partnership with NeRD Power for turnkey commercial solar projects, the launch of Free Solar 4 Veterans with The Warrior Up Foundation, and a Sustainable Community Network to bring no-cost solar to over 550 low-income homes in Washington D.C. Through a new joint venture and exclusive sales rights with Coulomb Capital, the company is scaling its efforts in tax credit monetization and entering the federal solar market. Lelantos also secured exclusive North American rights to a blockchain-based platform for automating carbon and renewable energy credit issuance, positioning itself as a first mover in the next wave of digital carbon trading.

Telomir Pharmaceuticals (NASDAQ: TELO) announced a $3 million equity investment from The Bayshore Trust, the company’s largest shareholder, through the purchase of 1 million restricted shares at $3.00 each—an 18% premium to the stock’s prior closing price. The raise brings total equity investment from affiliated entities to $4 million, complemented by an undrawn $5 million non-dilutive credit line. CEO Erez Aminov emphasized the company’s commitment to shareholder-friendly financing with no warrants or toxic structures. Telomir is advancing two key drug candidates: Telomir-1, a first-in-class age-reversal molecule with broad therapeutic potential, and Telomir-Ag2, a stabilized Silver(II) compound targeting drug-resistant infections. An IND submission for Telomir-1 is planned by year-end, with a focus on rare disease indications to demonstrate early efficacy.

U.S. President Donald Trump has made headlines again, this time not for politics, but for technology and global partnerships. During a high-level visit to the United Arab Emirates (UAE), Trump pledged strong support for the country’s artificial intelligence (AI) projects. He also announced massive new deals between American and Emirati companies, valued at a staggering $200 billion.

The International Energy Agency (IEA) estimates that as of 2024, over 80% of global photovoltaic solar panel production took place in China. Beijing dominates the global solar panel supply chain, and a vast majority of the solar panels installed across the U.S. were manufactured in the East Asian country.

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) has begun receiving and processing high-grade gold and silver ore from Talisker Resources at its upgraded $33 million Merritt Mill in British Columbia, the province’s only facility permitted to accept third-party precious metal feed. Production is expected to reach full capacity in Q3 2025, and Nicola has initiated a permit amendment to expand mill throughput. The Company is also preparing to receive ore from Blue Lagoon Resources’ Dome Mountain Mine and is advancing a bulk sample at its Dominion Creek project, in which it holds a 75% interest. Concurrently, Nicola is ramping up exploration at the New Craigmont Copper Project and has appointed Vicente García as Senior Geologist. CEO Peter Espig highlighted the company’s transition to a steady-state producer and emphasized the strategic value of its fully permitted infrastructure and long-term partnerships.

Silo Pharma (NASDAQ: SILO) announced a service agreement with Resyca BV to conduct a drug-device study on the microchip-enabled nasal spray system used in its lead PTSD treatment candidate, SPC-15. The study is intended to provide the final device data needed for an Investigational New Drug (IND) application to the FDA later this year. CEO Eric Weisblum noted the device’s ability to bypass the blood-brain barrier, potentially allowing faster and safer therapeutic delivery. Silo is also progressing two other SPC-15 studies, including a GLP-compliant toxicology study and a 7-day large animal safety trial requested by the FDA.

As sports investing gains traction among institutional investors, Brera Holdings (NASDAQ: BREA), a global sports investment group, is positioning itself as a public-market pioneer in the evolving space. With a growing global portfolio of sports clubs and a strategy grounded in sustainability and operational upside, Brera represents an emerging model for investors seeking exposure to professional sports.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the first patient has been dosed in the Phase 2 OASIS trial evaluating TNX-102 SL for reducing acute stress reaction (ASR) severity and the onset of acute stress disorder (ASD). Sponsored by the University of North Carolina’s Institute for Trauma Recovery and backed by a $3 million U.S. Department of Defense grant, the trial will enroll about 180 motor vehicle trauma survivors at emergency departments nationwide. TNX-102 SL previously showed improvements in sleep and early PTSD symptoms—factors seen as key to mitigating ASR. CEO Dr. Seth Lederman emphasized the urgent need for treatments following traumatic events in both civilian and military populations. Topline data is expected in the second half of 2026.

Gaxos.ai (NASDAQ: GXAI), a company developing artificial intelligence applications across various sectors, announced the official launch of UnGPT.ai, a real-time rewriting tool that converts machine-generated text into natural, human-quality content without compromising meaning. UnGPT leverages a proprietary multi-pass transformation model to deliver undetectable, high-quality output, outperforming leading AI detection tools. The platform includes features such as an adaptive text engine for tone tuning, contextual synonym intelligence, seamless browser integration, and recursive text refinement. CEO Vadim Mats said UnGPT “builds a bridge between raw LLM output and real-world usability.”

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) announced plans for its 2025 regional exploration program at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals under a 20/80 joint venture in which Aston Bay holds a free carried interest until a mine decision is made. CEO Thomas Ullrich highlighted key 2025 milestones, including the completion of an NI 43-101 Initial Mineral Resource Estimate, a $1 million royalty milestone payment from Taurus, and a strategic alliance with Ocean Partners to support near-surface copper development. The upcoming summer program will target new discoveries along a 110 km copper belt, expand known deposits, and support resource development through advanced geophysics and drilling. A Preliminary Economic Analysis for the near-surface mineralization is also underway, with impactful developments expected in the second half of the year.

Quantum BioPharma (NASDAQ: QNTM) has partnered with BitGo Trust Company to provide secure, institutional-grade custody for its Bitcoin, Solana, XRP, and DOGE holdings. The biopharmaceutical company, which is building a portfolio of innovative biotech assets, cited security and compliance as key drivers behind the selection of BitGo, known for its multi-signature wallets, cold storage solutions, and insurance-backed infrastructure. CEO Zeeshan Saeed said the partnership strengthens Quantum’s digital asset strategy while reinforcing public company standards.

Brera Holdings (NASDAQ: BREA) announced that S.S. Juve Stabia’s Serie B semifinal playoff match against Cremonese will stream live and air free today in the U.S., Canada and UK via Destination Calcio TV, with full English commentary. The broadcast reflects Brera’s commitment to internationalizing its portfolio club’s exposure as part of its multi-club ownership strategy. Executive Chairman Daniel McClory emphasized that expanding Juve Stabia’s global visibility during its Serie A playoff run showcases the company’s focus on fanbase growth and international media rights. The club, which finished 5th in Serie B, advanced to the semifinals after defeating Palermo 1-0.

OMS Energy Technologies (NASDAQ: OMSE) is a growth-oriented manufacturer of surface wellhead systems and oil country tubular goods for the oil and gas industry. The company recently closed its initial public offering of 3,703,704 ordinary shares, each at a public offering price of US$9.00, for a total base size of US$33.3 million. The ordinary shares began trading on the Nasdaq Capital Market under the symbol OMSE on May 13, and the offering closed on May 14, 2025. In addition, OMS granted the underwriter a 45-day option to purchase up to 555,555 additional ordinary shares at the public offering price, less underwriting discounts and commissions. Roth Capital Partners acted as sole manager for the offering.

For healthcare practices navigating the shift toward value-based care, the complexity of insurance contracts, quality metrics, and data reporting can be a barrier to better outcomes and stronger financial performance. Adageis, a growing healthcare technology company, is offering a unique streamlined and AI-powered software solution designed to make this transition simpler.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx is one of six companies invited to present at the high-profile event, which is expected to draw more than 1,000 attendees representing over $1 trillion in investment capital.

A proposal backed by Pennsylvania Democrats to allow adults to buy recreational marijuana from state-run stores has been blocked by a Senate panel . The bill was voted down 7-3 by the Senate Law and Justice Committee, with one Democrat siding with Republicans to oppose it.

The private credit market is on the cusp of substantial expansion in 2025, driven by a resurgence in global mergers and acquisitions (“M&A”), the digitization of lending processes and the emergence of innovative financing solutions tailored for small and medium-sized businesses (“SMBs”) ( https://ibn.fm/pDNA4 ). This confluence of factors is reshaping the financial landscape, as companies such as FAVO Capital (OTC: FAVO) are strengthening their foothold in the growing space.

Dr. Richard Lu, CEO of SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., offered insights into the company’s operations, strategy, and unique competitive position during a recent interview on IBN’s GotStocks podcast ( https://ibn.fm/UCIdQ ). The conversation centered on SolarBank’s dual role as both a developer and long-term owner of solar energy assets, an approach that differentiates the firm in a competitive market.

Beeline Holdings (NASDAQ: BLNE) announced the appointment of Frank Knuettel II to its board of directors, effective immediately. Knuettel brings over 20 years of executive leadership experience across early-stage public companies in technology and life sciences, and currently serves as CEO of Channel Therapeutics Corporation. Known for his capital markets expertise and M&A success, including leading Unrivaled Brands from $10 million to $100 million in revenue, Knuettel has raised more than $400 million throughout his career and held key roles at IP Commerce and MJardin Group. His appointment supports Beeline’s growth strategy in the investment lending market.

Siyata Mobile Inc. (NASDAQ: SYTA) is a technology company providing advanced communication solutions for frontline workers, emergency responders, and mobile workforces. Its core offerings include the SD7 push-to-talk handset and Uniden(R)-branded signal boosters, both designed to improve operational connectivity where traditional networks fall short. These products are FCC- and IC-certified and distributed through Tier-1 carriers, integrators, and government purchasing channels.

Tesla’s brand image has taken a significant hit in recent months. For at least a decade, Tesla was the darling of the burgeoning global electric vehicle segment. After launching the Tesla Roadster in 2008 and demonstrating the viability of mass market battery electric vehicles (BEVs), Tesla remained the most dominant player in the EV sector for most of its existence.

In recent weeks, the price of gold has experienced a significant drop, with analysts suggesting that investor sentiment has rapidly shifted, potentially contributing to the precious metal’s selloff. Despite the volatility, some major players are taking renewed interest in this precious metal, among them is billionaire investor Ray Dalio.

For many years, the scientific community has known that the risk of Multiple Sclerosis is markedly higher among people that have been exposed to the Epstein-Barr virus, the virus which causes infectious mononucleosis (commonly called “mono”). However, it isn’t clear why only a tiny fraction of individuals exposed to “mono” go on to develop MS.

UAE and U.S. presidents Sheikh Mohamed bin Zayed Al Nahyan and Donald Trump recently announced the launch of a massive artificial intelligence campus in Abu Dhabi during a high-profile event held at Qasr Al Watan.

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is expanding its international footprint by launching localized websites in Arabic, Italian, and Spanish. The initiative is part of the firm’s strategy to boost commercial activity across high-potential regions with growing demand for workplace safety and compliance solutions ( https://ibn.fm/odRAg ).

Mullen Automotive (NASDAQ: MULN) reported $5 million in revenue for the quarter ended March 31, 2025, a significant increase from $33,000 in the prior-year period, driven by deliveries of Class 1 and Class 3 electric vehicles to customers including logistics firms, local governments and universities. The company also highlighted new agreements, such as a supply deal with Enpower Greentech for advanced solid-state batteries and expanded public sector eligibility via Sourcewell contracts. Bollinger Motors, a majority-owned subsidiary, delivered Class 4 trucks but was placed into court-appointed receivership in May, a move Mullen says will not materially impact its liquidity. For the six-month period, Mullen recorded $7.9 million in revenue and a net loss of $162 million, with $118 million tied to non-cash expenses. Cash on hand declined to $2.3 million, and the company is continuing cost-reduction efforts and financing through convertible securities.

NextPlat (NASDAQ: NXPL, NXPLW) announced that its subsidiary, Global Telesat Communications Ltd (GTC), has been appointed the exclusive distributor for ZOLEO Inc. across the UK and European Economic Area. ZOLEO’s flagship global satellite communicator extends smartphone messaging coverage via the Iridium(R) satellite network and has earned accolades including Outdoor Retailer’s Innovation Award “Product of the Year.” The partnership adds to GTC’s expanding e-commerce and Amazon storefront portfolio of satellite connectivity solutions for remote workers, outdoor enthusiasts, and global travelers.

Cybin (NYSE American: CYBN) (NEO: CYBN) welcomed recent comments from FDA Commissioner Dr. Martin Makary endorsing the accelerated development of psychedelic therapeutics. The company, which is conducting Phase 3 trials of CYB003 for major depressive disorder (MDD) and Phase 2 trials of CYB004 for generalized anxiety disorder (GAD), said the FDA’s openness validates its mission to develop next-generation neuropsychiatric treatments. CYB003, a deuterated psilocin candidate, has received Breakthrough Therapy Designation, and early data show 100% response and 71% remission rates after two 16 mg doses. Cybin expects to launch the EMBRACE Phase 3 trial and complete its Phase 2 GAD study by mid-2025.